Women with certain cardiometabolic risk factors face a greater increase in risk for liver fibrosis than men with the same risk factors.

For patients with heart failure, prior authorization is associated with reduced and delayed filling of prescriptions for ARNIs and SGLT2is.

New ACC/AHA guidelines provide updated recommendations for dyslipidemia management, focusing on atherogenic lipoproteins and risk assessment.

AI use in federal health agencies has been garnering increasing interest due to its potential to expedite processes and improve efficiency.

A considerable proportion of adults with MCI or dementia develop new cardiovascular indications for anticoagulant and thrombolytic drugs.

Continuous IVC geometry monitoring helps patients with heart failure identify congestion and manage care via a smartphone application.

For children with single-ventricle disease, death or major morbidity occurs in 87%, and shunt type impact varies.

A federal judge has stopped a major effort to change the nation’s childhood vaccine schedule. The ruling, issued Monday in Massachusetts, blocks U.S. Health Secretary Robert F. Kennedy Jr.’s plan to ...

In patients with CF, pre-transplant PH is associated with improved early post-transplant survival, but with poorer outcomes after 3 years.

The FDA approves Wegovy HD (semaglutide 7.2 mg) for chronic weight management in adults with obesity or overweight and weight-related conditions.

Receiving the COVID-19 vaccine and booster reduced preeclampsia risk by nearly 60% in pregnant patients with preexisting morbidities.

Improving living environments for middle-aged and older Chinese adults may reduce stroke risk and help attenuate associated health burdens.